References
- Bonte J. Medroxyprogesterone in the management of primary and recurrent or metastatic uterine carcinoma. Acta Obstet Gynecol Scand, Suppl. 1972; 19: 21
- Engelsman E., Persijn J. P., Korsten C. B., Cleton F. J. Oestrogen receptor in human breast cancer tissue and response to Endocrine therapy. Br Med J 1973; 2: 750
- Engelsman E., Persijn J. P., Korsten C. B., Cle-ton F. J. Proceedings: oestrogen and androgen receptors in human breast cancer. Br J Cancer 1974; 30: 177
- EORTC Breast Cancer Co-operative Group. Eur J Cancer 1973; 9: 379
- Evans L. H., Martin J. D., Ahnel H. R. Estrogen receptor concentration in normal and pathological human uterine tissues. J. Clin Endocrinol Metabol 1974; 38: 23
- Haukkama M., Karjalainen O., Luukainen T. In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometrium. Am J Obstet Gynecol 1971; III: 205
- Jensen E. V., De Sombre E. R., Jungblut P. W. Endogenous factors influencing host-tumor balance, R. W. Wissler, T. L. Dao, S. Wood, Jr. Univ. Chicago Press, Chicago 1967
- Karlstedt K. Effect of progesterone on metastases and local recurrences of carcinoma of the uterine corpus. Acta Obstet Gynecol Scand, Suppl. 1972; 79: 11
- Korsten C. B., Engelsman E., Persijn J. P. Estrogen Receptors in Human Breast Cancer, W. L. Mc Guire, P. P. Carlon, E. P. Wolmer. Raven Press, New York 1975
- Kottmeier H. L. Review and personal experiences. Acta Obstet Gynecol Scand, Suppl. 1972; 19: 9
- Kullander S., Svanberg L. On climacteric symptoms and their treatment with a new non-steroidal estrogen. Int J Gynaecol Obstet 1975; 13: 277
- Kullander S., Tropé C. 1976, In press
- Laing L., Smith D., Caiman K., Leake R. Oestrogen-binding protein in plasma of breast-cancer patients (letter). Lancet 1976; II: 745
- Maass H., Breummer P., Egert D., Engel B., Holmeister H., Lehman F., Trams G. On the existence of receptors for estradiol in normal and malignant human tissue and the mode of action of progesterone: Acta Obstet Gynecol Scand, Suppl. 1972; 19: 30
- Persijn J. P., Korsten C. B., Engelsman E. Oestrogen and androgen receptors in breast cancer and response to endocrine therapy. Br Med J 1975; 4: 503
- Pollow K., Lübbert H., Boquoi E., Kreuzer G., Pollow B. Characerization and comparison of receptors for 17β-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma. Endocrinology 1975; 96: 1
- Rao B. R., Wiest W. G., Allen W. M. Progesterone “receptor” in human endometrium. Endocrinology 1974; 95: 1275
- Sherman A. I. Progesterone caproate in the treatment of endometrial cancer. Obstet Gynecol 1966; 28: 309
- Taylor R., Brush M. G., King R. J. B., Witt M. The uptake of oestrogen by endometrial carcinoma. Proc Roy Soc Med 1971; 64: 407
- Terenius L., Lindell A., Persson B. H. Binding of estradiol-17β to human cancer tissue of the female genital tract. Cancer Res 1971; 31: 1895
- Wagner R. K. Characterization and assay of steroid hormone receptors and steroid-binding serum proteins by agargel electrophoresis at low temperature. Hoppe-Seylers Zeitschrift Physiol Chem 1972; 353: 1235
- Wagner R. K., Jungblut P. W. Oestradiol- and dihydrotestosterone receptors in normal and neoplastic human mammary tissue. Acta Endocrinol (Kbh) 1976; 82: 105
- Young P. C. M., Cleary R. E. Characterization and properties of progesterone-binding components in human endometrium. J Clin Endocrinol 1974; 59: 425